{"id":904584,"date":"2025-11-03T17:54:42","date_gmt":"2025-11-03T22:54:42","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/"},"modified":"2025-11-03T17:54:42","modified_gmt":"2025-11-03T22:54:42","slug":"regeneron-announces-investor-conference-presentations-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/","title":{"rendered":"Regeneron Announces Investor Conference Presentations"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"start\">TARRYTOWN, N.Y., Nov.  03, 2025  (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0<strong>REGN<\/strong>) will webcast management participation as follows:<\/p>\n<ul>\n<li>Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025<\/li>\n<li>7<sup>th<\/sup> Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on Monday,\u00a0November 17, 2025<\/li>\n<li>8<sup>th<\/sup> Annual Evercore Healthcare Conference at 1:20 p.m. ET on Tuesday,\u00a0December 2, 2025<\/li>\n<li>Citi 2025 Global Healthcare Conference at 10:30 a.m. ET on Wednesday, December 3, 2025<\/li>\n<\/ul>\n<p align=\"start\">The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vGHfaH0jIaYFW_E7TgHh53300QqYXP9RRJJN7ll-njneoEriPoqtpRVFqJBEV9BU453ko-56DXR_dyLlZ5xQn0uaHkEQu3qwAI2LhcsebjNTnuBvEohzmz58WI04v7jz66Ci6J7HV2ZwisynGWWm6xWVoVsh8LyzBJa6KGzW_X01h4akdFjryPiu1IFNQrZWFyRhXV6RhYUy3LY6PwYfR4nRdAckYWxUsiShaJhPILClNFC08iFSQEuihMBJ4NOZMRFztNOwfQhRfGK_30USdznGt_CF5qeC6AWSMJiQNPAipROunZ7ovawNlxQd-KoLBKIxWEOtIvCQ1Xp0E1UDz0paxuJC2FLl53aCqy1LXCG4NpRUyVUhfOS70rKtbK7A-3k45p1ylTnysfpPVSbgvAjFNhGaLMQwhYLIXXTxhjhAU0K5OSMZSy4tU_ONgubJjPR5TZSD5SN9loCAeqQUDXTWIuPxX7F4ExcaWQk0Uw7ntnXf2D0pDX1EWMmPcfGAm7xXo69WdPnWNoHDXE7fIjK1mrYXfuvfLGxfSWdNtQlVA3zIrRbDSYOLYnfNJGaQ7QqLEkZ4ncHQGdgu_EeGEadaIpMys4S2JSQaWkzXUTew2oWjtfic5Yqxk0t1a66Zefu2cjTCmHkVhpRrcBjmNnPDTHBhcRNO-t7JgQJkPA4dRnYlUk2OxtxbQeXsyqU2C5jiEU1MepXpeLTVMxfuMvVQrIm-98k1Etypsov5P3abmC6obD_AABhAATYSOorPzJrNAeiSwwxZ7lH8Elx5Z1CBuix40NNVPdiJPk41TRVfou4xnSb6LrNsBYD2gqRcBS2WDNaM-6IP4zsTiCXjM_qJgd3BCD6EtBRCUHZoF-L8QoQxGVMsAgRsW23xZ7NCv98gdkkrrpYOMp9FGfyirQ==\" rel=\"nofollow\" target=\"_blank\">https:\/\/investor.regeneron.com\/events-and-presentations<\/a>. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days.<\/p>\n<p align=\"start\">\n        <strong>About Regeneron<\/strong><br \/>\n        <br \/>Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to\u00a0repeatedly and consistently translate science\u00a0into medicine has led to numerous approved treatments and\u202fproduct candidates in development, most of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious\u00a0diseases, and rare diseases.\u00a0<\/p>\n<p align=\"start\">Regeneron pushes the boundaries of scientific discovery and accelerates drug development using our proprietary technologies, such as <em>VelociSuite<\/em><sup><em>\u00ae<\/em><\/sup>, which produces optimized fully human antibodies and new classes of bispecific antibodies.\u202fWe are shaping the next frontier\u00a0of medicine with data-powered insights from the\u202fRegeneron Genetics Center<sup>\u00ae<\/sup>\u202fand pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases.<\/p>\n<p align=\"start\">For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dm8NYDgirzMGPi7scFn--RU-SLD2f14HyROCkNeDeDWugQmxCFZT_avPKLYbPOry3Oz0BaSGaKlELZ7oCcWq8BB71rGAA0uElksQZE-G3g8=\" rel=\"nofollow\" target=\"_blank\"><u>www.Regeneron.com<\/u><\/a> or follow Regeneron on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bgXfHgbTXHpStokzxVPhR2dUTh4Xeqy_onLmUTkllE4MWNRXPNw3tGzSXBl38wtJv-kxf0bog6OtU6TqQOtx6vR3qpNLzJkmABr3kugtDikQd-xlbZpJ2tLYeJZxQw88L5cvhV3hi0sCK3tkKV3rodAzDzlcGZEAPxkoWG1uQ-A=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tm-GagktbJ8j4tDklcmQS62BZ-6s5R2I_H6TIIJQBxZvfaDxy5EKdd22tQNkxn9MmtEjYOufwaBSyCJabLOXqCTEWY2WMuOErcxT4mT2ACC99d6XPsFgLygPa1ZzM968My83ftFqX3GEsM8p2h2C5i5z_xvbtYP3dpejk7n29kpRZ5yqejUVvyYoDXkGhaH4_-fg1Ju5C3Iayo51hRizFes2SMmjiaPWfq5p-gqM2jWzlzC1Bc5JQJR_xHwZQV6c\" rel=\"nofollow\" target=\"_blank\"><u>Instagram<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R3NHOExh7KMwQG5XKMNKPF9pg0zN_VQxRAYANVouPFuGnARnhDsMwv5U2USv2ZvwrfOmbfAZND78HnT8OtHD2eBHSz4GjZqdiLwegIaf83Fn7wCjt4weyF_WeJmYhe3W21tgcqV8f4173yXx7_4pf_IbqlaQg9HjXIbPWqa82xJzMxrxUyDsxMjEKIndNF-l4clO2Ex-aWNtT6wz43LMvTPBx2rePf1oiFRQmKwek7Ox3sqCKupJlcdsRR4MW0pF\" rel=\"nofollow\" target=\"_blank\"><u>Facebook<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UK134JZ0WLG3NmN-2_-mYcMperkWPqyDJ1Kjbe_rjqSuEq0itqBaVmQS-svKMTMXD_qsePHdpLyz4J6sB0WzLFj0A4BM94y4W-ebDVy460dfAE8RrO_i8-LmYudhKu5teOKbRCKbLSqw6m2k7ksHJpfzV3FpQ5viP4asngn-yKPgaeg8LZZhavUnSqIV67yPsx7H-e0Uf_XwTeIgHQ0oaA==\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>.<\/p>\n<p align=\"start\">\n        <strong>Contact Information:<\/strong><br \/>\n        <br \/>Investor Relations <br \/>Ryan Crowe <br \/>914.847.8790 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fq3fve3dLvjIFGIBsGXw-BdUrsOOmcEInzDVCRAoYViJlEU62tTV5eRnyBcVOuUmuBQlJrJi8rnAWCWCTvmFV4ltibWDXYTDMh4KjMTv0H3ehmVx_gJDevt4SoDb5Lyb\" rel=\"nofollow\" target=\"_blank\"><u>ryan.crowe@regeneron.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MDkyZThiM2UtMGIwMi00OGJiLWExOWQtM2Q2OWFkMjdiYWViLTEwMTc4MjMtMjAyNS0xMS0wMy1lbg==\/tiny\/Regeneron-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025 7th Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on Monday,\u00a0November 17, 2025 8th Annual Evercore Healthcare Conference at 1:20 p.m. ET on Tuesday,\u00a0December 2, 2025 Citi 2025 Global Healthcare Conference at 10:30 a.m. ET on Wednesday, December 3, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Regeneron Announces Investor Conference Presentations&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-904584","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Regeneron Announces Investor Conference Presentations - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025 7th Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on Monday,\u00a0November 17, 2025 8th Annual Evercore Healthcare Conference at 1:20 p.m. ET on Tuesday,\u00a0December 2, 2025 Citi 2025 Global Healthcare Conference at 10:30 a.m. ET on Wednesday, December 3, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and &hellip; Continue reading &quot;Regeneron Announces Investor Conference Presentations&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-03T22:54:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Regeneron Announces Investor Conference Presentations\",\"datePublished\":\"2025-11-03T22:54:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/\",\"name\":\"Regeneron Announces Investor Conference Presentations - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\",\"datePublished\":\"2025-11-03T22:54:42+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/regeneron-announces-investor-conference-presentations-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regeneron Announces Investor Conference Presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/","og_locale":"en_US","og_type":"article","og_title":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","og_description":"TARRYTOWN, N.Y., Nov. 03, 2025 (GLOBE NEWSWIRE) &#8212; Regeneron Pharmaceuticals, Inc. (NASDAQ:\u00a0REGN) will webcast management participation as follows: Jefferies London Healthcare Conference at 3:30 p.m. GMT (10:30 a.m. ET) on Monday, November 17, 2025 7th Annual Wolfe Research Healthcare Conference at 9:20 a.m. ET on Monday,\u00a0November 17, 2025 8th Annual Evercore Healthcare Conference at 1:20 p.m. ET on Tuesday,\u00a0December 2, 2025 Citi 2025 Global Healthcare Conference at 10:30 a.m. ET on Wednesday, December 3, 2025 The sessions may be accessed from the &#8220;Investors &amp; Media&#8221; page of Regeneron&#8217;s website at https:\/\/investor.regeneron.com\/events-and-presentations. Replays and transcripts of the webcasts will be archived on the Company&#8217;s website for at least 30 days. About Regeneron Regeneron\u00a0(NASDAQ: REGN) is a leading biotechnology company that invents,\u00a0develops\u00a0and &hellip; Continue reading \"Regeneron Announces Investor Conference Presentations\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-03T22:54:42+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Regeneron Announces Investor Conference Presentations","datePublished":"2025-11-03T22:54:42+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/","name":"Regeneron Announces Investor Conference Presentations - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=","datePublished":"2025-11-03T22:54:42+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU2NzMzMiM3MjQwMDUxIzIwMDYyNTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/regeneron-announces-investor-conference-presentations-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Regeneron Announces Investor Conference Presentations"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904584","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=904584"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/904584\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=904584"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=904584"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=904584"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}